INNOVA CAPTAB
Back to Cashflow Statement
|
INNOVA CAPTAB Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹92 Cr | ₹361 Cr | ₹27 Cr | ₹125 Cr | ₹-19 Cr |
What is the latest Cash Flow from Financing Activities ratio of INNOVA CAPTAB ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹92 Cr |
| Mar2024 | ₹361 Cr |
| Mar2023 | ₹27 Cr |
| Mar2022 | ₹125 Cr |
| Mar2021 | ₹-19 Cr |
How is Cash Flow from Financing Activities of INNOVA CAPTAB Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹92 Cr | -74.63 | |
| Mar2024 | ₹361 Cr | 1,231.88 | |
| Mar2023 | ₹27 Cr | -78.25 | |
| Mar2022 | ₹125 Cr | Positive | |
| Mar2021 | ₹-19 Cr | - | |
Compare Cash Flow from Financing Activities of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹4,890.9 Cr | -0.2% | 16.6% | -6.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | -0.2% |
16.6% |
-6.7% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses